Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Canada has also previously signed ... also in the “final stages of negotiation” to secure AstraZeneca and Oxford University’s vaccine, seen by many to be one of the most promising candidates.

This particular vaccine was designed for the KP.2 sublineage of Omicron, which was approved by Health Canada in September.

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

This season will be the first time in Ontario that nirsevimab (sold under the brand name Beyfortus) is used to protect babies ...

Canada, Denmark, Finland, France, New Zealand and Scotland. The report specifically looked at adverse events following ...

In Canada, switching to a one-dose, gender-neutral vaccination program for human papillomavirus (HPV) could use vaccine doses more efficiently and prevent a similar number of cervical cancer cases ...

On April 30, AstraZeneca admitted that the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis syndrome with thrombocytopenia ...

AstraZeneca has agreed to acquire U.S.-based vaccine developer Icosavax for $ ... since been approved for use in the European Union and Canada as well. Later in August, the FDA approved a second ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

Prime Minister Justin Trudeau got his flu and COVID-19 vaccines and is encouraging others to do the same. (Nov. 4, 2024) ...

The level of benefit from Covid vaccines is well documented. And the Oxford/AstraZeneca vaccine is credited with saving more lives in the first year of its use than any other - 6.3m globally ...